Company Insights

BKYI customer relationships

Explore interactive graphBrowse insights index
BKYI customer relationship map

BIO-key (BKYI) customer map: where revenue and risk converge

BIO-key International builds biometric-first identity and access management (IAM) software and hardware and monetizes through a mix of short-term subscription licenses, term SaaS agreements, perpetual licensing, hardware sales, and services—with recurring support and maintenance driving predictable revenue recognition. The company sells to enterprise, education and government customers globally through direct deals and an expanding network of regional distributors and integrators. For deeper visibility into customer relationships and sourcing, visit https://nullexposure.com/.

How BIO-key sells and how that shapes revenue

BIO-key’s commercial model is a hybrid of licensing and subscription economics. The company reports a weighted average contract duration of roughly one year and recognizes both license fees and annual recurring revenue from multi-year subscriptions; hardware and professional services are invoiced up front or on delivery. That contracting posture produces faster cash realization for one-off license and hardware sales, while the firm’s support, maintenance and multi-year SaaS contracts generate ARR that smooths top-line volatility. The company also discloses a material weakness in revenue controls that is being remediated—an important governance signal for buyers of its revenue durability.

  • Contracting posture: Short-term weighted average duration (~1 year) with both licensing and subscription lines.
  • Revenue mix: Software (perpetual and subscription), hardware sold at point-in-time, plus support and professional services billed in advance or T&M.
  • Geographic footprint: Revenue concentrated in North America and EMESA/Africa with smaller Asia contribution.
  • Customer types: Enterprise, education, and government customers are explicitly represented in the revenue disclosures.

Explore an investor-focused view of BIO-key’s customer exposure at https://nullexposure.com/.

Relationship roll call — what every public signal says

Below are all customer and channel relationships referenced in filings and press coverage. Each entry is a concise plain‑English summary plus the primary source.

Bank of Egypt

BIO-key announced a win with the Bank of Egypt roughly ten months prior to its 2025 Q3 earnings call, indicating a commercial deployment in the banking sector. This came up on BIO-key’s 2025 Q3 earnings call (first reported in March 2026).

Source: BIO-key 2025 Q3 earnings call (mentioned Mar 2026).

Sociedade Interbancária de Moçambique (SIMO)

SIMO selected BIO-key under a multi‑year strategic agreement to secure Mozambique’s national electronic payments network with PortalGuard® and tokenless authentication; the deal is positioned as a national payments infrastructure engagement and has been reported across press outlets and an 8‑K. Multiple press notices appeared in Feb–Mar 2026 (including QuiverQuant and related press coverage).

Source: Company press releases and SEC 8‑K reporting summarized in March 2026 press coverage (QuiverQuant / StockTitan / GlobeNewswire).

IT2Trust

IT2Trust signed a distribution and support agreement to carry BIO-key’s full IAM and biometric portfolio across the Nordic region, positioning IT2Trust as a channel partner for sales, deployment and local support. The arrangement was publicized in a GlobeNewswire press release and syndicated media in late 2025.

Source: GlobeNewswire press release (Oct 27, 2025) and subsequent coverage.

Visualforma

Visualforma was awarded a contract to lead a nationwide rollout of BIO-key’s IAM and biometric technologies across Portugal’s public‑sector network—described as covering more than 250 government organizations—positioning Visualforma as the integrator for a major municipal rollout. The award was announced via GlobeNewswire in January 2026 and covered by other outlets.

Source: GlobeNewswire press release (Jan 28, 2026) and related press reports.

SAVIS Group

SAVIS Group was appointed as an authorized distributor to bring BIO-key’s IAM and biometric solutions into Vietnam, providing localized pre‑sales, deployment and technical support through its partner ecosystem. This partnership was disclosed in a GlobeNewswire release in November 2025.

Source: GlobeNewswire press release (Nov 17, 2025).

Citadel Global

BIO-key’s EMEA subsidiary partnered with Citadel Global to expand presence in India, using Citadel’s local infrastructure for pre‑sales, deployment and customer success while delivering the BIO-key portfolio via a Mumbai presence. The arrangement was announced in late January 2026 releases.

Source: GlobeNewswire press release (Jan 29, 2026) and syndicated stock news (Mar 2026).

VaporVM

VaporVM will integrate and promote BIO-key’s full IAM and biometric portfolio in its region, providing partner enablement, deployment services and local support as a cloud distribution channel. This was covered in a Yahoo Finance press release and related news in early 2026.

Source: Yahoo Finance press release (reported 2026).

Capitec Bank

Capitec Bank in South Africa uses BIO-key’s biometric technology for both employee access and customer access, cited by management as an operational case comparable to other institutional deployments during the 2025 Q3 earnings discussion.

Source: BIO-key 2025 Q3 earnings call (mentioned Mar 2026).

Ed Tech JPA

BIO-key’s PortalGuard has been made available to an Ed Tech Joint Powers Authority covering approximately 195 K‑12 institutions, positioning education as a meaningful vertical expansion for the IAM platform. The arrangement was reported in syndicated press in early 2026.

Source: StockTitan news summary (Mar 2026).

Arrow ECS Iberia

Arrow ECS Iberia is listed among prior channel deals that broaden BIO-key’s reach in Iberia, used as a distribution pathway into that market. This channel relationship was described in regional expansion announcements in early 2026.

Source: StockTitan syndicated coverage (Mar 2026).

Cloud Distribution Co.

Cloud Distribution Co. (named in press coverage) is cited as one of several distribution partners used to broaden BIO-key’s reach across multiple territories, forming part of the company’s channel‑led expansion strategy referenced in early 2026 reports.

Source: StockTitan syndicated coverage (Mar 2026).

What investors should take from the relationship map

BIO-key’s commercial progress is unmistakable: the company is actively converting channel partnerships and targeted government/financial-sector wins into geographically diversified revenue streams, with notable traction across Africa, Iberia, Portugal’s public sector, Vietnam, India and the Nordics. That said, several structural business model signals require attention:

  • Contracting concentration and duration: BIO-key’s revenue mix tilts toward short‑term contracts and licensing fees coupled with annually recurring subscriptions—this produces faster cash from license/hardware sales but leaves ARR modest relative to a pure SaaS scale model.
  • Channel-driven expansion: Multiple distributor and integrator relationships (IT2Trust, Visualforma, VaporVM, SAVIS, Citadel, Arrow ECS) accelerate market access but introduce revenue aggregation and margin variability through third‑party partners.
  • Government and financial criticality: Government and national payments infrastructure customers (e.g., SIMO, Bank of Egypt, Portuguese municipalities) increase deal value and strategic visibility; such customers are highly critical but can concentrate political and implementation risk.
  • Operational controls and maturity: The company disclosed a material weakness related to revenue recognition that it worked to remediate in 2024—this is a governance and financial reporting risk until fully closed.
  • Geographic exposure: Reported revenues show heavy North American share with significant Africa and EMESA contributions and smaller Asia exposure, which aligns with the observed customer list.

For investors focused on revenue durability and channel execution, BIO-key’s profile is a mid‑stage IAM vendor with measurable enterprise and government traction but still dependent on short-term contracts and partner economics. For an analytic deep dive and ongoing monitoring of customer signals, visit https://nullexposure.com/.

Bottom line and next steps

BIO-key demonstrates a clear go‑to‑market: combine core biometric IAM IP with local integrators to win large public‑sector and banking mandates while sustaining recurring support revenue. Key upside drivers are continued channel rollouts and expansion of national payments and municipal deployments; key risks are revenue concentration, short contract tenors, and prior control weaknesses.

If you evaluate customer relationships or underwrite partner risk, the sourcing above provides a concise map of active commercial links. Learn more about monitoring customer signals and relationship evidence at https://nullexposure.com/.